Login to Your Account



Biogen Idec Getting Conforma In Buyout Worth Up To $250M

By Karen Pihl-Carey


Thursday, May 4, 2006
In an effort to augment its oncology pipeline, Biogen Idec Inc. signed a definitive merger agreement to acquire Conforma Therapeutics Corp. for $150 million at closing, plus up to $100 million in development milestone payments. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription